We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Approvable Letter Delays Release of Novartis Diabetes Drug
Approvable Letter Delays Release of Novartis Diabetes Drug
February 26, 2007
The FDA’s request for more information on Novartis’ Type 2 diabetes treatment Galvus could significantly delay the drug’s release, the company said.